We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GlycoMimetics (GLYC) in Focus: Stock Moves 9.2% Higher
Read MoreHide Full Article
GlycoMimetics, Inc. (GLYC - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 26.2% in the past one-month time frame.
The company has seen three positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for GlycoMimetics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
GlycoMimetics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Is GLYC going up? Or down? Predict to see what others think: Up or Down.
Can Hackers Put Money INTO Your Portfolio?
Earlier this month, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.
Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.
Image: Bigstock
GlycoMimetics (GLYC) in Focus: Stock Moves 9.2% Higher
GlycoMimetics, Inc. (GLYC - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 26.2% in the past one-month time frame.
The company has seen three positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for GlycoMimetics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
GlycoMimetics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
GlycoMimetics, Inc. Price
GlycoMimetics, Inc. Price | GlycoMimetics, Inc. Quote
A better-ranked stock in the Medical sector is MEI Pharma, Inc. (MEIP - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is GLYC going up? Or down? Predict to see what others think: Up or Down.
Can Hackers Put Money INTO Your Portfolio?
Earlier this month, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.
Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.
Download the new report now>>